Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Enterprise Value (2016 - 2026)

Biomerica's Enterprise Value history spans 17 years, with the latest figure at -$1.3 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 56.31% to -$1.3 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$1.3 million, a 56.31% increase, with the full-year FY2025 number at -$3.1 million, up 26.67% from a year prior.
  • Enterprise Value hit -$1.3 million in Q1 2026 for Biomerica, up from -$2.5 million in the prior quarter.
  • Over the last five years, Enterprise Value for BMRA hit a ceiling of -$1.3 million in Q1 2026 and a floor of -$10.2 million in Q1 2022.
  • Historically, Enterprise Value has averaged -$4.9 million across 5 years, with a median of -$4.2 million in 2024.
  • Biggest five-year swings in Enterprise Value: plummeted 92.96% in 2022 and later surged 67.12% in 2023.
  • Tracing BMRA's Enterprise Value over 5 years: stood at -$5.1 million in 2022, then crashed by 40.81% to -$7.1 million in 2023, then skyrocketed by 66.75% to -$2.4 million in 2024, then decreased by 7.21% to -$2.5 million in 2025, then surged by 47.46% to -$1.3 million in 2026.
  • Business Quant data shows Enterprise Value for BMRA at -$1.3 million in Q1 2026, -$2.5 million in Q4 2025, and -$3.1 million in Q3 2025.